Delivery Order SPE2DE24D0021-SPE2D625F1PJQ
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,540.27 on August 4, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by August 11, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued without a set-aside designation, reflecting...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Defense Medical Supply Chain on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment provisions represents a child contract under a larger vehicle and carries no set-aside designation. The order is scheduled for completion by August 26, 2025, with performance directed to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Medical Supply Chain, a defense-affiliated federal agency, on June 2, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). The contract is structured as a fixed-price agreement with economic price adjustment provisions and is set to be completed by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. This award represents a...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F1PJQDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no set-aside designation, indicating open competition procurement. Fisher Scientific, a major supplier of scientific products, equipment, and services to federal agencies since 2001, leveraged its established capabilities in medical equipment and specialized testing solutions to secure this delivery order. As a critical vendor supporting healthcare and testing initiatives across multiple federal departments, Fisher Scientific continues to demonstrate its ability to rapidly deliver specialized medical supplies to government agencies. The abbreviated timeline for this contract reflects the pressing need for COVID-19 testing capabilities within the Medical Supply Chain. This award aligns with Fisher Scientific's extensive contract portfolio with agencies including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense, underscoring its role as a reliable provider of laboratory and medical products to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/21/25 |